Cue Biopharma (CUE) announced that it is commencing an underwritten public offering of shares of its common stock and accompanying warrants to purchase shares of common stock. All of the securities are being offered by Cue Biopharma. Oppenheimer & Co. is acting as sole book-running manager for the offering. Newbridge Securities is acting as co-manager for the offering.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CUE: